JSSH
AXSM icon

J. Safra Sarasin Holding’s Axsome Therapeutics AXSM Stock Holding History

J. Safra Sarasin Holding’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Sell
3,806
-823
-18% -$178K 0.01% 408
2026
Q1 		$782K Sell
4,629
-2,754
-37% -$476K 0.01% 343
2025
Q4 		$1.35M Sell
7,383
-1,514
-17% -$211K 0.02% 244
2025
Q3 		$1.08M Sell
8,897
-10,761
-55% -$1.21M 0.02% 310
2025
Q2 		$2.05M Buy
19,658
+9,998
+103% +$1.06M 0.04% 216
2025
Q1 		$1.13M Buy
+9,660
New +$1.1M 0.02% 299

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

J. Safra Sarasin Holding's AXSM Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Axsome Therapeutics (AXSM) stake by 18% in Q2 2026, selling an estimated $178K and leaving 3,806 shares worth $932K. The position accounts for 0.01% of the portfolio, ranked #408.

J. Safra Sarasin Holding first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.05M in Q2 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • J. Safra Sarasin Holding held 3,806 shares of Axsome Therapeutics worth $932K as of Q2 2026.
  • J. Safra Sarasin Holding sold 823 Axsome Therapeutics shares in Q2 2026, an estimated $178K.
  • Axsome Therapeutics made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #408 holding.
  • J. Safra Sarasin Holding first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • J. Safra Sarasin Holding's Axsome Therapeutics position peaked at $2.05M in Q2 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.